Radiostics offers subspecialized consulting and image interpretation to clinical research organizations (CROs) conducting industry-sponsored trials with imaging end points. We are leaders in independent radiology review of phase 1 through 4 drug and device trials and work closely with regulatory officials. Find out more.
Our network of independent radiologists and image readers are located across the U.S. and can provide the services remotely. This allows us to connect you to an experienced group of professionals with the subspecialty expertise to meet the needs of your complex clinical trials. Find out more.
Radiostics' professionals have the the specific field knowledge you need with rigorous QA and QC procedures. We also have access to innovative imaging technology that is designed to reduce errors and inter-observer variability.